rfhg_191193.1

Basic information about the TSS

---

TSS ID: rfhg_191193.1 Species: human Chr: chr17		Start: 28350449 End: 28350471 Strand: -
Source datasets	PRJDB5282
Protocol	C1CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: AL110156:-60 GeneID: 26073 HGNC/MGI_ID: HGNC:23781 UniProt_ID: Q9UG21 Nearer transcript ids and distances:

Gene_name: DNA polymerase delta interacting protein 2 Gene_symbol: POLDIP2 Gene_synonyms: DKFZP586F1524 PDIP38 Gene_source: HGNC:23781

TATA-Box annotation

---

Distance to TSS:	7067
Nearest PromoterID:	NM_015584
Entrez ID:	26073
Nearest Unigene:	Hs.241543
Nearest Refseq:	NM_015584
Nearest Ensembl:	ENSG00000004142
Gene Name:	DNA polymerase delta interacting protein 2
Gene Alias:	PDIP38|POLD4|p38
Gene Type:	protein-coding
CpG%:	0.090909
GC%:	0.739130
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@POLDIP2 p2@POLDIP2 p3@POLDIP2
Sample		p1@POLDIP2	p2@POLDIP2	p3@POLDIP2
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	65.06	1.95	1.75
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	72.43	2.02	1.42
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	63.47	1.16	1.35
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	49.27	1.46	1.46
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	52.87	0.67	1.12
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	54.27	1.16	1.74
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	82.14	3.27	1.74
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	75.57	2.42	2.42
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	87.62	3.21	4.06
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	93.90	4.64	1.74
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	80.85	4.04	2.83
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	78.46	3.25	1.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	34.50	0.81	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	35.63	0.60	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	34.69	0.22	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	29.93	0.50	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	32.98	0.66	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	28.68	0.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	22.39	0.00	1.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	34.30	0.60	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	33.81	0.80	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	35.39	0.35	0.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	33.48	0.52	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	31.30	0.00	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	31.73	0.26	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	28.80	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	32.42	0.00	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	37.96	0.47	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	34.40	0.16	1.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	36.01	0.54	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	33.70	0.42	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	26.57	0.59	0.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	34.40	0.42	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	30.18	0.16	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	35.53	0.75	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	36.98	0.96	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	39.04	0.41	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	32.84	0.60	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	35.11	0.54	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	34.57	0.00	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	39.99	0.47	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	30.74	0.44	0.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	34.38	0.84	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	35.14	0.35	0.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	38.15	1.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	31.41	0.23	0.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	37.91	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	31.89	0.60	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	31.84	0.72	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	34.78	0.20	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	31.56	0.82	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	37.58	0.44	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	30.16	0.71	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	30.49	0.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	16.78	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	23.88	0.92	1.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	37.27	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	34.69	0.64	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	31.75	0.00	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	31.73	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	32.53	0.56	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	23.88	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	25.48	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	31.19	0.32	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	29.11	0.00	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	23.69	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	22.91	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	20.83	0.00	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	25.80	0.47	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	24.84	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	30.01	0.31	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	33.94	0.00	0.00
Adipocyte - breast, donor1	11376-118A8	31.04	0.79	0.32
Adipocyte - breast, donor2	11327-117E4	38.82	0.80	0.80
Adipocyte - omental, donor1	11473-119C6	31.81	0.25	0.89
Adipocyte - omental, donor2	11474-119C7	32.89	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	27.80	0.67	0.00
Adipocyte - perirenal, donor1	11476-119C9	24.24	0.64	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	28.59	1.10	1.10
Adipocyte - subcutaneous, donor2	11336-117F4	35.68	0.90	0.90
Adipocyte - subcutaneous, donor3	11408-118E4	52.83	0.52	0.87
Adipocyte differentiation, day04, donor1	13019-139D4	50.07	0.98	0.39
Adipocyte differentiation, day04, donor2	13022-139D7	31.40	1.29	0.51
Adipocyte differentiation, day04, donor3	13025-139E1	35.96	1.39	0.84
Adipocyte differentiation, day04, donor4	13028-139E4	39.38	0.00	1.18
Adipocyte differentiation, day08, donor1	13020-139D5	69.01	1.37	1.85
Adipocyte differentiation, day08, donor2	13023-139D8	32.60	0.65	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	22.93	0.00	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	32.27	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	69.04	1.25	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	36.67	0.50	1.00
Adipocyte differentiation, day12, donor3	13027-139E3	45.49	0.65	0.65
Adipocyte differentiation, day12, donor4	13030-139E6	46.58	0.61	0.91
Alveolar Epithelial Cells, donor1	11510-119G7	46.63	1.33	1.99
Alveolar Epithelial Cells, donor2	11590-120G6	67.77	1.08	2.15
Alveolar Epithelial Cells, donor3	11671-122G6	25.16	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	32.92	0.54	0.90
Amniotic Epithelial Cells, donor2	11613-122A2	28.45	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	38.83	0.41	0.41
Anulus Pulposus Cell, donor1	11248-116E6	43.94	1.14	1.14
Anulus Pulposus Cell, donor2	11463-119B5	41.39	0.24	1.22
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	22.02	0.00	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	17.80	0.43	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	27.82	0.00	2.14
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	22.72	0.30	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	31.62	1.26	1.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	29.04	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	18.52	0.00	0.65
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	24.76	0.00	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	24.35	0.59	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	20.34	0.00	1.51
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	24.67	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	21.31	0.00	1.25
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	28.01	0.49	0.16
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	20.47	1.36	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	30.46	0.15	0.30
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	21.43	0.54	0.54
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	26.64	0.94	0.38
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	21.12	0.53	0.53
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	16.58	0.00	0.98
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	29.19	0.50	0.83
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	30.02	1.20	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	14.16	3.54	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	24.19	0.34	0.51
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	12.58	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	24.76	0.49	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	26.56	0.38	1.14
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	24.23	0.00	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	34.77	0.00	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	27.36	0.43	0.64
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	29.42	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	27.68	0.00	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	25.72	0.64	1.61
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	21.40	0.00	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	17.55	0.58	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	25.29	0.00	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	29.70	2.38	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	25.94	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	23.69	0.76	0.25
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	19.70	0.00	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	23.30	0.86	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	25.83	0.21	0.42
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	23.20	0.00	0.29
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	29.29	0.00	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	25.94	0.17	0.68
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	20.85	0.00	2.32
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	23.24	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	28.09	0.86	0.43
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	21.66	0.60	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	14.58	0.73	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	32.64	0.23	0.46
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	15.30	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	27.97	0.76	0.51
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	27.87	1.03	1.03
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	23.56	0.31	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	26.77	0.48	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	33.70	0.00	0.44
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	13.73	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	26.59	0.00	0.55
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	26.74	0.26	0.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	22.90	0.36	0.00
Astrocyte - cerebellum, donor1	11500-119F6	60.18	1.72	1.84
Astrocyte - cerebellum, donor2	11580-120F5	64.87	1.03	2.23
Astrocyte - cerebellum, donor3	11661-122F5	53.49	2.10	0.84
Astrocyte - cerebral cortex, donor1	11235-116D2	51.94	1.74	2.44
Astrocyte - cerebral cortex, donor2	11316-117D2	49.99	2.10	0.97
Astrocyte - cerebral cortex, donor3	11392-118C6	57.58	2.24	1.94
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	41.06	2.18	1.72
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	48.11	2.38	1.50
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	41.54	2.39	1.93
Basophils, donor1	12241-129G9	21.97	0.00	0.78
Basophils, donor2	12242-129H1	19.48	0.72	0.00
Basophils, donor3	12243-129H2	29.99	0.73	0.59
Bronchial Epithelial Cell, donor1	11511-119G8	36.22	0.86	0.65
Bronchial Epithelial Cell, donor2	11591-120G7	33.83	0.91	0.46
Bronchial Epithelial Cell, donor3	11672-122G7	50.21	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	60.88	0.00	3.14
Bronchial Epithelial Cell, donor5	11457-119A8	63.42	1.25	1.25
Bronchial Epithelial Cell, donor6	11461-119B3	36.62	0.23	1.84
Bronchial Epithelial Cell, donor7	11769-123I5	27.17	0.36	0.36
Burkitt's lymphoma cell line:DAUDI	10422-106C8	60.60	1.34	1.34
Burkitt's lymphoma cell line:RAJI	10476-106I8	73.60	2.56	1.40
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	52.76	0.96	2.24
CD133+ stem cells - cord blood derived, pool1	12223-129E9	41.37	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	23.11	0.00	0.56
CD14+ Monocytes, donor2	11305-117B9	18.56	0.19	0.19
CD14+ Monocytes, donor3	11381-118B4	21.73	0.00	1.10
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	35.10	0.00	0.57
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	28.81	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	33.20	0.33	0.66
CD14+ monocytes - mock treated, donor1	11863-125A9	16.77	0.43	1.45
CD14+ monocytes - mock treated, donor2	11873-125C1	14.48	0.30	0.30
CD14+ monocytes - mock treated, donor3	11883-125D2	17.53	0.47	0.47
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	9.21	0.50	0.17
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	13.52	0.28	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	10.66	0.74	0.99
CD14+ monocytes - treated with BCG, donor1	11860-125A6	10.38	0.78	0.20
CD14+ monocytes - treated with BCG, donor2	11870-125B7	12.29	1.25	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	14.36	0.22	0.44
CD14+ monocytes - treated with Candida, donor1	11868-125B5	9.37	0.47	0.23
CD14+ monocytes - treated with Candida, donor2	11878-125C6	7.39	1.58	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	16.64	1.11	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	13.24	0.30	0.45
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	16.16	0.80	0.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	12.08	0.00	0.42
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	10.30	0.46	0.92
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	8.82	0.23	0.23
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	6.98	1.31	0.87
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	12.37	0.27	0.54
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	17.45	0.52	0.17
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	15.15	0.84	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	9.55	0.73	0.37
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	9.86	0.35	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	10.53	1.32	0.88
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	10.46	0.87	0.52
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	11.15	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	14.01	1.29	0.43
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	11.88	0.00	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	8.81	0.46	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	9.05	0.23	0.23
CD14+CD16+ Monocytes, donor1	11789-124B7	17.87	0.22	0.22
CD14+CD16+ Monocytes, donor2	11801-124D1	21.02	0.23	0.46
CD14+CD16+ Monocytes, donor3	11912-125G4	17.55	0.43	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	24.92	0.62	0.16
CD14+CD16- Monocytes, donor2	11799-124C8	20.96	0.17	0.52
CD14+CD16- Monocytes, donor3	11910-125G2	19.84	0.22	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	20.16	0.00	1.02
CD14-CD16+ Monocytes, donor2	11800-124C9	18.66	0.44	0.44
CD14-CD16+ Monocytes, donor3	11911-125G3	20.42	0.63	0.63
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	34.55	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	29.15	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	44.53	0.00	1.04
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	26.12	0.53	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	27.88	1.07	0.54
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	30.18	0.00	0.70
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	27.45	1.57	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	38.23	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	30.41	0.82	0.00
CD19+ B Cells, donor2	11624-122B4	18.86	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	22.21	0.00	0.50
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	84.45	0.81	1.21
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	80.30	0.80	2.00
CD34+ Progenitors, donor1	11545-120B6	28.11	1.00	0.00
CD34+ Progenitors, donor2	11625-122B5	24.72	0.56	0.56
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	54.86	1.88	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	63.59	1.58	0.90
CD4+ T Cells, donor1	11225-116C1	27.14	0.36	0.36
CD4+ T Cells, donor2	11306-117C1	33.68	1.22	1.84
CD4+ T Cells, donor3	11382-118B5	27.45	0.61	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	25.52	0.00	0.77
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	31.67	0.22	0.22
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	34.50	0.29	0.57
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	27.02	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	34.41	1.40	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	36.26	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	21.53	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	30.33	0.34	0.17
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	27.89	0.16	0.48
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	21.52	0.45	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	27.60	0.00	0.35
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	22.88	0.00	0.44
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	19.82	0.42	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	30.96	0.62	1.04
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	26.40	1.00	0.67
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	32.09	0.27	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	28.94	1.07	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	21.52	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	31.52	0.74	0.56
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	31.84	0.87	0.65
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	32.36	0.00	0.21
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	18.71	0.00	0.51
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	31.19	0.00	0.43
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	28.76	0.44	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	39.59	0.49	0.99
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	28.62	0.00	0.92
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	36.29	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	32.68	0.55	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	31.16	0.74	0.74
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	24.64	0.00	1.54
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	37.60	1.79	0.36
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	47.09	1.38	0.00
CD8+ T Cells, donor1	11226-116C2	31.43	0.00	0.00
CD8+ T Cells, donor2	11307-117C2	24.03	1.13	0.75
CD8+ T Cells, donor3	11383-118B6	34.34	0.50	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	43.81	0.46	0.92
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	33.07	0.96	0.72
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	39.67	2.46	2.46
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	27.62	0.60	0.60
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	28.32	0.72	1.92
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	30.47	1.14	1.14
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	46.28	0.87	0.87
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	38.43	0.26	1.32
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	45.26	1.64	1.17
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	46.79	0.60	0.91
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	41.83	1.74	0.87
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	45.03	1.60	1.07
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	26.27	0.88	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	27.78	0.00	0.46
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	18.65	0.75	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	38.54	1.80	1.08
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	37.40	1.44	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	34.18	1.18	1.18
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	58.63	0.63	0.63
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	42.44	0.92	0.92
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	43.92	0.32	1.28
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	39.78	0.00	1.15
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	35.86	1.18	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	34.04	1.51	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	27.30	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	27.98	0.70	0.70
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	36.06	3.01	1.00
Cardiac Myocyte, donor1	11525-119I4	73.11	0.00	1.83
Cardiac Myocyte, donor2	11605-120I3	43.48	0.49	0.49
Cardiac Myocyte, donor3	11686-122I3	48.30	0.42	0.63
Chondrocyte - de diff, donor1	11261-116G1	43.33	0.35	1.39
Chondrocyte - de diff, donor2	11338-117F6	36.96	0.71	0.36
Chondrocyte - de diff, donor3	11410-118E6	38.80	0.23	0.11
Chondrocyte - re diff, donor2	11339-117F7	32.23	0.00	0.90
Chondrocyte - re diff, donor3	11411-118E7	42.87	1.21	1.21
Ciliary Epithelial Cells, donor1	11242-116D9	46.25	1.38	0.80
Ciliary Epithelial Cells, donor2	11323-117D9	44.25	1.92	0.64
Ciliary Epithelial Cells, donor3	11399-118D4	45.93	0.97	0.88
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	74.55	3.48	1.65
Corneal Epithelial Cells, donor1	11526-119I5	51.60	0.44	0.88
Corneal Epithelial Cells, donor2	11606-120I4	40.95	1.14	2.28
Corneal Epithelial Cells, donor3	11687-122I4	58.03	1.02	2.30
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	32.19	0.33	0.33
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	30.28	0.32	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	31.06	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	27.54	0.32	0.32
Dendritic Cells - plasmacytoid, donor1	11228-116C4	33.48	1.02	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	37.21	1.31	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	32.91	0.00	0.48
Endothelial Cells - Aortic, donor0	11207-116A1	66.37	1.50	2.50
Endothelial Cells - Aortic, donor1	11263-116G3	49.88	0.59	1.17
Endothelial Cells - Aortic, donor2	11340-117F8	49.77	0.00	1.41
Endothelial Cells - Aortic, donor3	11412-118E8	57.01	0.79	0.79
Endothelial Cells - Artery, donor1	11264-116G4	41.01	1.75	1.45
Endothelial Cells - Artery, donor2	11341-117F9	50.58	1.65	0.71
Endothelial Cells - Artery, donor3	11413-118E9	68.72	0.88	1.75
Endothelial Cells - Lymphatic, donor1	11236-116D3	30.37	0.22	0.22
Endothelial Cells - Lymphatic, donor2	11317-117D3	26.78	0.00	0.91
Endothelial Cells - Lymphatic, donor3	11393-118C7	17.20	0.00	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	28.82	1.19	0.59
Endothelial Cells - Microvascular, donor2	11342-117G1	39.05	0.52	2.08
Endothelial Cells - Microvascular, donor3	11414-118F1	31.48	0.57	0.57
Endothelial Cells - Thoracic, donor1	11266-116G6	40.81	1.20	1.20
Endothelial Cells - Thoracic, donor2	11343-117G2	33.54	1.05	1.05
Endothelial Cells - Umbilical vein, donor1	11243-116E1	50.44	0.99	0.62
Endothelial Cells - Umbilical vein, donor2	11324-117E1	53.45	1.09	1.96
Endothelial Cells - Umbilical vein, donor3	11400-118D5	56.06	0.98	1.71
Endothelial Cells - Vein, donor1	11267-116G7	87.59	2.28	2.28
Endothelial Cells - Vein, donor2	11344-117G3	58.67	1.40	1.40
Endothelial Cells - Vein, donor3	11416-118F3	66.73	1.26	1.10
Eosinophils, donor1	12244-129H3	45.74	0.00	0.00
Eosinophils, donor2	12245-129H4	29.70	1.65	0.00
Eosinophils, donor3	12246-129H5	10.70	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	28.10	0.24	0.98
Esophageal Epithelial Cells, donor2	11587-120G3	37.44	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	16.27	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	33.25	0.00	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	26.72	0.77	0.55
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	42.14	0.54	0.98
Fibroblast - Aortic Adventitial, donor1	11245-116E3	42.21	0.73	0.85
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	22.38	0.96	0.96
Fibroblast - Aortic Adventitial, donor2	11326-117E3	31.64	0.74	0.42
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	13.44	0.79	0.53
Fibroblast - Aortic Adventitial, donor3	11401-118D6	41.52	1.00	1.00
Fibroblast - Cardiac, donor1	11268-116G8	49.90	0.00	0.91
Fibroblast - Cardiac, donor2	11345-117G4	56.09	1.52	0.76
Fibroblast - Cardiac, donor3	11417-118F4	41.64	0.32	0.95
Fibroblast - Cardiac, donor4	11452-119A3	38.49	0.30	0.30
Fibroblast - Cardiac, donor5	11456-119A7	36.80	0.51	0.63
Fibroblast - Cardiac, donor6	11460-119B2	42.60	0.30	1.21
Fibroblast - Choroid Plexus, donor1	11492-119E7	35.24	0.94	0.80
Fibroblast - Choroid Plexus, donor2	11572-120E6	31.49	0.00	0.86
Fibroblast - Choroid Plexus, donor3	11653-122E6	57.13	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	69.65	2.31	3.00
Fibroblast - Conjunctival, donor3	11692-122I9	33.92	1.02	0.51
Fibroblast - Dermal, donor1	11269-116G9	45.31	0.70	0.47
Fibroblast - Dermal, donor2	11346-117G5	71.22	1.89	0.00
Fibroblast - Dermal, donor3	11418-118F5	44.49	0.73	1.09
Fibroblast - Dermal, donor4	11450-119A1	36.17	1.24	0.45
Fibroblast - Dermal, donor5	11454-119A5	34.37	1.22	1.40
Fibroblast - Dermal, donor6	11458-119A9	40.28	0.65	0.97
Fibroblast - Gingival, donor1	11237-116D4	46.02	1.04	1.25
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	56.59	0.52	0.00
Fibroblast - Gingival, donor2	11318-117D4	45.99	1.19	1.32
Fibroblast - Gingival, donor3	11394-118C8	37.13	0.87	0.68
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	44.67	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	28.90	0.53	0.35
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	65.79	1.87	1.25
Fibroblast - Gingival, donor6 (control)	11922-125H5	54.90	0.68	0.81
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	38.11	0.71	0.35
Fibroblast - Gingival, donor7 (control)	11924-125H7	55.57	1.46	1.02
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	48.41	0.55	0.68
Fibroblast - Gingival, donor8 (control)	11926-125H9	67.90	1.54	0.77
Fibroblast - Gingival, donor9 (control)	11927-125I1	35.07	0.15	1.03
Fibroblast - Lung, donor1	11270-116H1	46.22	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	37.30	0.00	1.49
Fibroblast - Lung, donor3	11419-118F6	63.94	1.90	2.11
Fibroblast - Lymphatic, donor1	11506-119G3	57.48	2.50	5.83
Fibroblast - Lymphatic, donor2	11586-120G2	34.97	0.00	1.40
Fibroblast - Lymphatic, donor3	11667-122G2	36.38	0.56	0.28
Fibroblast - Mammary, donor1	11540-120B1	63.33	1.22	1.62
Fibroblast - Mammary, donor2	11620-122A9	51.92	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	29.78	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	41.90	0.97	0.97
Fibroblast - Periodontal Ligament, donor2	11319-117D5	46.72	0.46	1.21
Fibroblast - Periodontal Ligament, donor3	11395-118C9	42.84	0.31	0.61
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	39.69	1.53	1.91
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	51.03	1.08	0.81
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	33.17	0.46	0.35
Fibroblast - Pulmonary Artery, donor1	11250-116E8	52.61	0.77	1.44
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	51.00	1.83	1.02
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	52.79	0.67	1.34
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	43.89	0.79	0.79
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	19.65	1.19	0.60
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	28.77	0.53	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	29.56	0.79	0.79
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	23.77	0.90	0.90
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	34.98	0.76	0.43
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	23.79	0.51	0.25
Fibroblast - skin normal, donor1	11553-120C5	35.11	0.33	0.33
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	28.47	1.00	0.60
Fibroblast - skin normal, donor2	11561-120D4	32.75	1.00	0.50
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	28.11	0.30	0.60
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	32.14	0.83	0.66
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	29.75	0.17	0.34
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	16.09	0.99	0.99
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	34.83	1.28	1.07
Fibroblast - skin walker warburg, donor1	11554-120C6	49.93	0.84	1.01
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	30.74	0.31	0.16
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	51.42	0.87	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	32.07	0.87	0.52
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	34.87	0.78	0.52
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	39.86	0.26	1.53
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	48.23	1.53	3.06
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	58.06	1.28	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	51.63	1.14	1.43
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	59.29	0.55	1.10
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	48.18	0.91	1.14
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	45.77	1.19	2.58
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	51.55	1.06	0.79
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	57.73	1.63	1.30
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	52.62	3.10	1.33
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	41.69	0.42	0.71
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	45.93	0.99	0.74
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	39.76	1.07	0.27
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	41.50	1.12	0.99
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	45.82	1.94	0.55
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	33.54	0.20	0.20
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	38.56	0.91	0.46
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	38.62	1.37	0.50
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	37.60	1.53	0.87
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	53.48	1.18	0.59
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	41.33	2.07	1.75
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	43.12	1.79	0.89
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	37.50	1.21	0.81
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	38.00	1.87	0.68
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	38.93	1.42	2.31
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	35.69	1.46	0.94
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	35.01	1.37	0.68
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	42.60	0.89	0.66
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	38.10	0.92	0.92
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	29.81	1.23	0.61
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	38.58	1.24	1.03
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	41.04	1.27	1.04
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	45.19	1.17	0.33
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	34.83	0.22	0.44
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	44.52	0.86	0.74
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	45.22	0.65	0.16
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	44.90	0.32	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	43.02	1.33	1.14
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	42.71	1.58	0.63
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	41.36	0.30	0.91
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	42.13	0.73	1.36
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	37.32	0.88	0.44
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	40.12	0.56	0.84
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	44.44	1.67	1.02
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	46.53	0.80	0.53
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	47.58	1.07	0.77
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	48.32	0.91	0.65
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	52.59	1.36	1.08
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	39.08	0.55	0.55
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	30.27	0.44	0.22
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	30.74	0.99	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	31.40	1.45	0.66
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	34.70	0.40	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	44.22	0.76	0.76
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	42.60	0.60	0.80
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	44.07	0.62	0.62
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	57.69	0.61	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	58.21	1.25	1.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	54.53	2.26	1.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	40.12	1.38	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	59.40	2.47	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	56.47	0.39	1.55
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	41.72	3.21	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	45.21	0.00	1.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	36.78	0.33	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	46.53	1.65	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	36.65	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	36.63	1.12	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	42.49	1.31	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	41.10	0.84	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	41.03	2.23	0.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	37.02	0.68	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	64.73	0.00	4.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	49.82	1.15	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	47.36	0.00	0.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	50.82	3.39	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	54.26	0.83	0.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	44.18	1.61	0.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	36.88	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	37.67	2.31	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	41.72	1.63	1.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	52.84	0.67	0.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	43.92	1.16	1.93
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	69.15	0.68	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	54.67	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	47.19	0.00	1.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	44.66	0.60	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	56.46	0.00	0.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	41.48	0.00	0.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	47.86	1.48	0.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	53.12	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	40.84	1.75	1.17
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	46.52	0.44	0.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	40.69	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	42.98	0.00	1.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	32.03	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	61.63	0.00	1.14
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	49.07	0.83	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	85.46	2.25	2.25
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	31.08	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	30.08	1.25	1.25
Hep-2 cells mock treated, biol_rep1	11898-125E8	74.96	0.93	2.09
Hep-2 cells mock treated, biol_rep2	11899-125E9	67.69	2.19	1.52
Hep-2 cells mock treated, biol_rep3	11900-125F1	66.89	1.59	1.59
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	75.75	1.42	2.08
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	71.35	2.15	0.86
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	65.23	1.72	1.08
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	73.48	1.37	2.12
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	60.90	1.20	1.54
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	58.63	0.64	1.92
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	22.38	0.00	1.12
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	46.74	1.30	0.87
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	34.37	2.64	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	58.90	1.06	1.41
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	50.13	0.73	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	40.74	1.22	1.05
Hepatocyte, donor1	11523-119I2	108.95	0.00	1.21
Hepatocyte, donor2	11603-120I1	88.34	1.08	1.08
Hepatocyte, donor3	11684-122I1	100.01	2.45	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	54.17	2.61	1.31
Intestinal epithelial cells (polarized), donor1	11246-116E4	128.11	1.57	1.57
Iris Pigment Epithelial Cells, donor1	11530-119I9	33.75	0.96	1.23
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	57.31	6.37	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	73.43	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	58.14	1.38	6.92
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	70.07	5.01	2.50
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	94.95	11.87	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	74.32	0.00	2.56
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	63.99	9.14	9.14
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	87.71	3.25	1.62
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	43.35	1.67	5.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	58.09	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	72.79	2.65	1.32
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	54.32	2.22	2.22
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	47.14	5.24	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	62.36	0.00	2.52
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	58.77	1.55	1.55
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	43.90	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	70.42	1.29	2.58
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	64.40	1.61	1.61
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	83.64	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	77.41	3.26	1.63
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	74.31	3.36	3.78
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	43.12	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	75.55	0.00	0.80
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	59.09	0.00	1.85
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	15.08	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	53.34	1.89	1.42
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	70.74	1.81	1.81
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	14.74	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	61.34	2.15	3.23
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	90.20	3.81	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	98.58	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	70.14	0.64	1.28
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	61.97	0.00	1.82
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	47.41	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	67.84	2.14	1.43
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	73.00	3.32	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	53.71	1.23	1.85
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	54.44	1.76	1.76
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	110.01	0.00	9.43
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	63.98	0.70	3.48
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	73.03	0.00	2.21
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	58.36	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	60.16	0.87	3.49
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	87.74	4.50	4.50
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	90.60	0.00	3.48
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	77.87	2.13	1.07
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	74.81	0.00	4.16
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	74.09	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	76.40	0.00	0.92
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	30.25	6.05	3.03
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	74.50	0.00	6.21
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	69.79	3.17	3.17
Keratinocyte - epidermal, donor1	11272-116H3	31.58	0.49	1.14
Keratinocyte - epidermal, donor2	11349-117G8	46.85	2.93	1.17
Keratinocyte - epidermal, donor3	11421-118F8	41.93	0.38	0.76
Keratinocyte - oral, donor1	11251-116E9	48.93	1.02	1.25
Keratocytes, donor1	11527-119I6	52.26	1.03	4.47
Keratocytes, donor2	11607-120I5	52.73	1.17	2.34
Keratocytes, donor3	11688-122I5	35.96	2.77	2.57
Krukenberg tumor cell line:HSKTC	10687-109F3	54.95	2.20	2.20
Lens Epithelial Cells, donor1	11529-119I8	45.31	0.00	1.08
Lens Epithelial Cells, donor2	11609-120I7	39.10	1.61	2.19
Lens Epithelial Cells, donor3	11690-122I7	42.68	0.71	1.41
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	34.86	0.59	0.83
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	26.23	0.28	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	29.75	0.47	0.47
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	23.66	0.00	1.08
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	18.91	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	27.28	0.11	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	16.01	0.41	0.82
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	34.89	0.76	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	25.19	0.42	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	20.57	0.00	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	25.98	0.19	0.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	29.25	0.19	0.74
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	27.18	0.00	0.35
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	26.00	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	26.78	0.41	0.82
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	21.87	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	26.19	0.94	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	36.60	0.18	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	26.33	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	29.87	0.29	0.88
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	30.62	0.75	0.25
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	21.82	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	25.58	0.27	0.54
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	28.76	0.91	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	24.88	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	27.43	0.00	0.42
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	31.13	0.30	0.75
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	24.08	0.69	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	25.40	0.38	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	27.99	0.00	0.32
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	21.32	0.97	0.97
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	20.18	0.99	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	28.37	0.12	0.50
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	27.77	0.00	1.11
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	23.47	0.25	0.49
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	25.30	0.27	0.41
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	18.33	0.32	0.64
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	27.39	0.61	0.61
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	23.65	0.84	0.84
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	25.96	0.00	1.07
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	25.21	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	30.50	0.78	0.93
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	29.72	0.36	1.07
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	25.81	0.00	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	27.54	0.47	0.47
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	33.41	0.37	0.74
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	28.94	0.51	0.51
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	30.43	0.00	0.60
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	47.59	2.27	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	45.26	4.60	0.77
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	37.11	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	35.97	2.12	1.69
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	40.09	2.81	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	33.62	0.00	1.87
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	29.89	1.55	0.52
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	40.44	2.38	1.19
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	49.31	2.26	2.49
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	34.32	1.45	1.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	38.72	2.25	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	42.00	1.90	2.17
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	32.87	1.03	1.03
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	34.93	2.47	2.82
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	29.98	0.00	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	38.20	1.02	1.53
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	40.29	2.40	1.60
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	40.43	1.51	1.13
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	41.11	1.23	0.61
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	54.63	1.63	1.63
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	42.69	1.67	1.67
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	36.43	0.56	1.68
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	46.37	2.06	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	40.64	2.03	2.32
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	29.00	1.20	1.20
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	36.51	1.11	1.66
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	51.61	1.77	0.71
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	35.77	1.84	1.11
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	49.50	2.30	2.30
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	51.04	2.30	0.77
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	28.31	2.26	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	40.20	1.64	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	48.80	1.36	2.26
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	43.81	1.44	1.44
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	38.84	1.49	2.24
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	43.85	2.97	1.49
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	31.88	0.43	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	34.25	1.71	1.71
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	49.98	1.00	2.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	28.96	1.21	2.41
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	54.04	0.71	3.55
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	48.46	2.41	1.37
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	43.48	3.22	1.07
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	39.73	0.00	2.69
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	47.04	1.85	1.85
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	54.66	2.33	1.16
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	47.60	1.06	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	43.22	1.20	1.60
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	43.61	0.73	2.18
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	54.42	1.53	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	49.33	1.97	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	36.70	0.00	1.88
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	58.33	4.02	2.01
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	42.36	2.70	2.70
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	34.42	3.44	3.44
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	53.00	3.12	2.67
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	56.31	0.78	1.96
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	32.99	1.32	1.32
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	56.56	2.08	1.56
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	45.51	0.88	1.31
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	41.37	1.68	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	41.96	0.88	2.65
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	50.53	1.54	2.70
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	34.43	2.03	1.52
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	49.98	0.48	0.96
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	41.34	3.18	1.59
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	32.20	1.82	1.82
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	34.59	1.38	3.46
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	52.06	3.04	1.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	36.67	1.03	0.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	31.44	0.60	1.81
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	47.54	3.80	2.54
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	42.65	0.53	1.60
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	34.48	1.15	2.30
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	44.22	2.06	1.03
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	47.39	0.71	0.71
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	36.89	2.27	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	53.67	3.33	2.08
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	39.15	0.00	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	37.16	1.25	1.67
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	51.11	2.79	1.86
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	40.14	1.34	2.68
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	40.63	0.53	0.53
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	55.77	1.21	4.45
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	46.81	0.00	2.75
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	36.45	2.67	1.78
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	60.98	2.28	0.57
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	46.78	2.30	3.07
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	30.64	1.64	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	52.12	2.23	1.78
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	65.77	2.86	3.64
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	49.07	1.33	1.33
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	62.36	2.08	0.00
Macrophage - monocyte derived, donor1	11232-116C8	31.68	0.46	0.91
Macrophage - monocyte derived, donor2	11313-117C8	30.46	0.37	0.73
Macrophage - monocyte derived, donor3	11389-118C3	38.41	0.92	0.13
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	41.95	1.06	0.00
Mallassez-derived cells, donor2	11929-125I3	29.47	0.32	0.95
Mallassez-derived cells, donor3	11930-125I4	35.44	0.56	0.97
Mammary Epithelial Cell, donor1	11273-116H4	47.93	0.50	0.80
Mammary Epithelial Cell, donor2	11350-117G9	35.61	0.58	0.00
Mammary Epithelial Cell, donor3	11422-118F9	58.62	1.75	1.50
Mast cell - stimulated, donor1	11487-119E2	18.30	0.00	0.68
Mast cell, donor1	11563-120D6	24.55	0.97	0.76
Mast cell, donor2	11565-120D8	20.51	0.89	1.19
Mast cell, donor3	11566-120D9	17.78	0.23	0.45
Mast cell, donor4	11567-120E1	19.68	0.18	0.35
Mast cell, expanded and stimulated, donor5	11940-126A5	21.96	0.44	0.00
Mast cell, expanded and stimulated, donor8	11942-126A7	23.35	0.58	0.00
Mast cell, expanded, donor5	11939-126A4	22.14	0.80	1.03
Mast cell, expanded, donor8	11941-126A6	25.61	0.67	0.33
Melanocyte - dark, donor1	11502-119F8	42.39	0.20	0.50
Melanocyte - dark, donor2	11582-120F7	41.18	0.35	0.35
Melanocyte - dark, donor3	11663-122F7	53.10	0.43	1.23
Melanocyte - light, donor1	11274-116H5	39.96	1.41	1.65
Melanocyte - light, donor2	11351-117H1	50.50	0.68	1.36
Melanocyte - light, donor3	11423-118G1	35.56	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	47.79	0.42	0.94
Melanocyte, donor2 (MC+2)	12739-135I3	43.84	0.81	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	35.62	0.54	0.00
Meningeal Cells, donor1	11493-119E8	45.78	1.49	1.86
Meningeal Cells, donor2	11573-120E7	44.45	0.88	0.44
Meningeal Cells, donor3	11654-122E7	41.81	0.57	1.22
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	60.45	1.71	2.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	23.65	0.50	0.30
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	52.57	0.00	1.31
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	66.72	2.62	1.31
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	71.04	0.72	2.15
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	29.22	0.42	0.64
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	40.21	0.50	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	70.98	1.54	1.32
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	70.87	0.73	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	67.72	1.43	1.02
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	27.01	0.83	0.83
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	43.49	0.74	2.60
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	35.39	0.66	0.66
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	45.99	0.89	0.30
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	39.70	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	62.76	1.92	1.28
Mesenchymal stem cells - adipose, donor0	11217-116B2	59.19	0.35	1.77
Mesenchymal stem cells - hepatic, donor0	11218-116B3	38.47	0.00	0.63
Mesenchymal stem cells - umbilical, donor0	11214-116A8	46.44	0.73	0.73
Mesothelial Cells, donor1	11247-116E5	37.39	0.80	1.33
Mesothelial Cells, donor2	12156-128G5	42.54	1.50	2.00
Mesothelial Cells, donor3	11402-118D7	27.24	0.36	0.87
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	74.27	0.00	1.35
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	32.26	0.49	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	38.57	0.29	0.59
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	93.34	0.00	3.46
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	31.61	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	26.14	0.41	0.21
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	50.95	2.32	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	37.29	0.00	0.50
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	27.46	0.47	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	58.40	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	24.79	0.41	0.81
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	30.09	1.19	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	51.31	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	21.24	0.00	0.88
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	30.39	0.38	0.38
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	52.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	25.47	0.21	0.42
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	31.31	0.00	2.76
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	20.86	0.30	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	35.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	135.80	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	16.06	0.50	0.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	28.28	0.24	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	29.30	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	14.97	0.23	0.23
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	22.09	0.00	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	19.77	0.20	0.20
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	17.38	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	21.34	0.67	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	51.59	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	15.99	0.66	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	26.36	0.51	0.51
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	54.68	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	22.29	0.27	0.27
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	23.82	0.00	0.29
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	21.81	1.09	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	17.30	0.96	0.96
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	21.21	0.00	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	39.77	1.37	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	16.52	1.00	0.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	20.39	2.04	2.04
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	16.64	0.00	1.31
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	45.25	1.10	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	35.22	0.64	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	20.83	0.50	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	30.62	0.70	0.70
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	61.88	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	17.78	0.00	0.68
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	38.95	0.88	0.44
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	33.73	1.07	0.36
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	21.32	1.12	0.28
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	38.24	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	32.05	0.00	0.58
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	18.70	0.30	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	32.97	0.42	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	86.63	0.00	7.22
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	30.48	0.00	0.92
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	31.30	1.14	0.57
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	24.73	0.69	0.55
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	19.95	0.00	0.26
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	25.31	0.43	0.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	41.29	0.64	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	23.49	1.07	0.80
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	27.24	0.00	0.30
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	19.63	0.00	0.28
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	15.29	0.32	0.64
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	31.18	0.44	0.66
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	31.09	0.76	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	16.19	0.00	0.28
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	23.84	0.49	0.25
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	29.98	0.00	1.30
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	19.99	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	34.31	0.58	0.86
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	21.02	0.41	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	21.44	0.30	0.60
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	45.20	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	24.95	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	26.29	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	28.40	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	26.29	0.20	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	13.04	2.79	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	30.04	1.50	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	26.37	0.27	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	22.73	0.11	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	21.37	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	23.82	0.73	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	20.22	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	19.77	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	27.05	7.73	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	32.32	0.00	1.01
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	23.19	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	6.81	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	1.27	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	3.24	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	13.59	0.00	1.51
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	28.55	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	42.41	0.00	3.26
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	33.27	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	75.29	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	38.35	0.43	0.65
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	37.63	0.52	1.57
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	40.05	0.00	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	39.65	0.42	0.42
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	62.75	0.57	1.71
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	90.96	1.60	4.79
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	29.24	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	12.86	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	25.95	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	53.23	0.00	1.39
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	30.00	0.81	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	30.27	0.21	0.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	33.40	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	33.75	0.50	0.99
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	28.15	0.27	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	29.47	0.00	0.45
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	25.64	0.33	0.49
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	28.61	0.36	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	29.17	0.53	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	30.02	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	28.88	0.66	0.33
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	24.39	0.16	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	31.22	0.00	0.53
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	28.13	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	23.45	0.46	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	34.38	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	34.14	0.34	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	32.87	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	35.65	0.45	0.89
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	28.37	0.42	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	26.82	0.00	0.47
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	41.64	0.43	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	27.08	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	26.66	0.33	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	31.11	0.45	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	23.01	0.79	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	26.93	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	31.03	0.38	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	25.42	0.33	0.65
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	26.58	0.00	1.31
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	34.37	0.90	0.90
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	22.93	0.00	0.88
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	27.26	1.33	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	30.75	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	21.82	0.38	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	29.03	0.30	0.60
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	25.42	0.66	0.44
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	26.43	0.68	0.68
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	25.55	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	37.80	0.61	0.61
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	29.59	0.31	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	29.36	0.00	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	28.48	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	29.47	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	15.17	0.00	0.00
Myoblast, donor1	11241-116D8	40.75	0.75	1.24
Myoblast, donor2	11322-117D8	48.14	0.77	2.69
Myoblast, donor3	11398-118D3	51.96	2.02	2.02
NK T cell leukemia cell line:KHYG-1	10777-110G3	83.47	1.61	2.63
Natural Killer Cells, donor1	11230-116C6	25.83	0.00	0.00
Natural Killer Cells, donor2	11311-117C6	24.43	1.51	0.30
Natural Killer Cells, donor3	11387-118C1	28.16	0.55	0.37
Neural stem cells, donor1	11275-116H6	34.12	1.45	0.73
Neural stem cells, donor2	11352-117H2	48.14	0.00	3.85
Neurons, donor1	11494-119E9	42.10	7.97	5.69
Neurons, donor2	11574-120E8	51.74	5.28	2.64
Neurons, donor3	11655-122E8	56.73	3.29	1.64
Neutrophils, donor1	11233-116C9	16.70	0.93	0.93
Neutrophils, donor2	11314-117C9	8.70	0.00	2.90
Neutrophils, donor3	11390-118C4	15.27	1.83	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	42.39	0.59	1.07
Nucleus Pulposus Cell, donor2	11409-118E5	35.82	0.65	1.30
Nucleus Pulposus Cell, donor3	11462-119B4	29.88	1.20	1.80
Olfactory epithelial cells, donor1	11933-125I7	34.69	0.14	0.96
Olfactory epithelial cells, donor2	11934-125I8	46.03	0.14	0.58
Olfactory epithelial cells, donor3	11935-125I9	39.84	0.23	0.57
Olfactory epithelial cells, donor4	11936-126A1	38.28	0.49	0.68
Oligodendrocyte - precursors, donor1	11496-119F2	44.53	1.20	0.00
Osteoblast - differentiated, donor1	11276-116H7	38.71	0.43	0.64
Osteoblast - differentiated, donor2	11353-117H3	25.15	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	42.83	0.00	0.62
Osteoblast, donor1	11277-116H8	96.55	2.74	1.76
Osteoblast, donor2	11354-117H4	44.25	0.70	0.00
Osteoblast, donor3	11426-118G4	84.60	1.96	1.96
Pancreatic stromal cells, donor1	11249-116E7	42.96	0.84	0.59
Pericytes, donor1	11491-119E6	39.94	0.56	0.67
Pericytes, donor2	11571-120E5	40.29	0.68	1.13
Pericytes, donor3	11652-122E5	40.49	1.42	1.02
Perineurial Cells, donor1	11499-119F5	38.43	0.79	0.79
Perineurial Cells, donor2	11579-120F4	45.45	1.75	1.20
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	23.91	0.00	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	18.85	0.00	0.24
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	18.51	0.65	0.00
Placental Epithelial Cells, donor1	11278-116H9	63.86	2.15	2.15
Placental Epithelial Cells, donor2	11355-117H5	43.25	1.11	1.11
Placental Epithelial Cells, donor3	11427-118G5	44.17	0.98	1.18
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	37.34	0.63	0.63
Preadipocyte - breast, donor1	11467-119B9	23.07	0.00	0.19
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	23.23	0.13	0.39
Preadipocyte - breast, donor2	11328-117E5	36.47	0.45	0.45
Preadipocyte - omental, donor1	11468-119C1	25.89	0.11	0.43
Preadipocyte - omental, donor2	11329-117E6	34.04	0.87	0.44
Preadipocyte - omental, donor3	11403-118D8	37.24	1.00	1.15
Preadipocyte - perirenal, donor1	11469-119C2	29.53	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	92.75	0.92	2.46
Preadipocyte - subcutaneous, donor2	11356-117H6	54.36	1.24	0.35
Preadipocyte - subcutaneous, donor3	11428-118G6	61.64	0.68	2.04
Preadipocyte - visceral, donor1	11280-116I2	49.74	1.30	0.84
Preadipocyte - visceral, donor2	11357-117H7	37.27	2.30	1.38
Preadipocyte - visceral, donor3	11429-118G7	44.62	1.36	1.15
Prostate Epithelial Cells (polarized), donor1	11253-116F2	135.16	5.13	3.77
Prostate Epithelial Cells, donor2	11331-117E8	22.21	0.41	0.41
Prostate Epithelial Cells, donor3	11404-118D9	20.33	0.92	1.29
Prostate Stromal Cells, donor1	11254-116F3	54.22	1.59	1.37
Prostate Stromal Cells, donor2	11332-117E9	52.89	0.36	0.72
Prostate Stromal Cells, donor3	11405-118E1	36.81	0.63	0.52
Renal Cortical Epithelial Cells, donor1	11516-119H4	46.72	1.46	0.36
Renal Cortical Epithelial Cells, donor2	11596-120H3	26.75	0.49	0.97
Renal Epithelial Cells, donor1	11517-119H5	65.43	2.03	4.06
Renal Epithelial Cells, donor2	11597-120H4	48.37	0.71	0.71
Renal Epithelial Cells, donor3	11678-122H4	28.27	0.64	0.32
Renal Glomerular Endothelial Cells, donor1	11514-119H2	36.09	1.36	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	42.72	0.81	1.35
Renal Glomerular Endothelial Cells, donor3	11675-122H1	51.06	0.22	0.89
Renal Glomerular Endothelial Cells, donor4	11783-124B1	41.26	0.67	0.67
Renal Mesangial Cells, donor1	11518-119H6	56.12	1.54	0.44
Renal Mesangial Cells, donor2	11598-120H5	48.90	0.00	1.88
Renal Mesangial Cells, donor3	11679-122H5	57.42	0.55	0.83
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	73.55	2.15	2.42
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	49.76	1.69	1.69
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	58.63	3.28	1.93
Retinal Pigment Epithelial Cells, donor0	11215-116A9	48.74	2.07	3.37
Retinal Pigment Epithelial Cells, donor1	11528-119I7	44.34	2.56	2.27
Retinal Pigment Epithelial Cells, donor2	11608-120I6	56.60	4.12	1.03
Retinal Pigment Epithelial Cells, donor3	11689-122I6	30.36	2.51	1.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	70.96	0.80	0.94
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	21.44	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	6.60	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	13.34	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	20.02	0.65	0.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	23.63	1.09	0.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	26.43	0.45	0.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	20.96	0.99	0.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	25.29	0.47	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	26.81	1.39	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	17.39	0.82	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	23.14	0.61	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	30.64	0.90	1.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	16.64	0.72	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	24.36	0.64	0.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	25.22	1.33	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	15.10	0.76	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	23.85	0.65	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	21.99	0.19	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	19.38	1.46	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	25.70	0.68	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	25.02	0.76	1.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	20.61	0.64	0.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	25.23	0.84	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	24.61	1.54	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	18.42	1.28	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	23.67	0.49	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	31.97	1.34	0.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	15.57	0.47	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	20.63	1.19	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	32.50	0.47	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	15.97	1.24	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	22.34	0.66	1.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	32.38	1.46	0.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	19.92	0.81	0.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	32.19	0.51	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	29.30	0.96	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	17.54	0.52	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	29.08	0.69	1.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	28.73	1.15	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	14.32	1.36	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	33.44	0.89	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	20.79	1.87	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	21.02	0.69	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	28.81	1.67	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	27.81	0.81	1.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	18.18	0.75	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	34.24	0.70	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	29.62	0.91	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	18.73	0.86	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	31.15	0.29	0.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	31.03	0.61	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	17.18	0.90	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	28.50	0.45	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	23.66	0.30	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	23.50	0.94	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	29.88	0.64	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	34.26	0.60	0.00
Schwann Cells, donor1	11498-119F4	59.62	1.88	1.69
Schwann Cells, donor2	11578-120F3	27.22	0.00	0.00
Schwann Cells, donor3	11659-122F3	44.47	2.85	1.53
Sebocyte, donor1	11220-116B5	38.34	0.55	0.55
Sebocyte, donor2	11301-117B5	29.87	0.92	1.38
Sebocyte, donor3	11378-118B1	38.96	0.21	0.62
Sertoli Cells, donor1	11255-116F4	31.48	0.00	1.66
Sertoli Cells, donor2	11333-117F1	33.89	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	45.31	0.97	1.58
Skeletal Muscle Cells, donor2	11358-117H8	36.87	1.45	0.72
Skeletal Muscle Cells, donor3	11430-118G8	85.28	2.51	1.67
Skeletal Muscle Cells, donor4	11451-119A2	50.90	0.63	1.41
Skeletal Muscle Cells, donor5	11455-119A6	41.32	1.04	1.49
Skeletal Muscle Cells, donor6	11459-119B1	56.94	2.00	0.62
Skeletal Muscle Satellite Cells, donor1	11240-116D7	49.77	0.63	0.50
Skeletal Muscle Satellite Cells, donor2	11321-117D7	48.80	0.86	0.86
Skeletal Muscle Satellite Cells, donor3	11397-118D2	65.88	1.39	1.79
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	34.96	0.67	0.76
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	77.44	4.34	3.62
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	55.59	1.93	0.69
Skin - palm, donor1	10286-104F7	59.09	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	19.89	0.43	0.14
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	12.27	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	21.68	0.26	0.52
Small Airway Epithelial Cells, donor1	11256-116F5	23.91	0.56	0.42
Small Airway Epithelial Cells, donor2	11334-117F2	25.60	0.14	0.98
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	39.12	0.85	0.21
Small Airway Epithelial Cells, donor3	11406-118E2	20.54	0.45	0.52
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	27.77	0.93	1.54
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	10.00	0.22	0.22
Smooth Muscle Cells - Aortic, donor0	11210-116A4	68.19	2.35	1.76
Smooth Muscle Cells - Aortic, donor1	11283-116I5	43.76	0.44	2.43
Smooth Muscle Cells - Aortic, donor2	11360-117I1	52.77	0.79	3.15
Smooth Muscle Cells - Aortic, donor3	11432-118H1	60.26	2.32	1.55
Smooth Muscle Cells - Bladder, donor1	11519-119H7	44.03	1.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	45.38	0.53	0.93
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	41.01	0.66	1.33
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	53.64	1.15	0.26
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	41.68	0.33	1.63
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	54.64	1.48	1.48
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	34.74	0.57	1.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	61.82	1.46	2.44
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	50.54	3.04	2.13
Smooth Muscle Cells - Carotid, donor1	11285-116I7	56.83	0.76	1.52
Smooth Muscle Cells - Carotid, donor2	11362-117I3	257.07	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	51.98	1.91	0.95
Smooth Muscle Cells - Colonic, donor1	11239-116D6	36.13	1.03	0.88
Smooth Muscle Cells - Colonic, donor2	11320-117D6	29.49	0.22	1.08
Smooth Muscle Cells - Colonic, donor3	11396-118D1	46.81	1.05	1.15
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	62.03	0.77	1.24
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	102.40	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	37.95	1.49	1.20
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	58.72	2.73	1.71
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	31.25	0.86	0.79
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	36.53	0.70	1.21
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	39.59	0.91	0.46
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	39.85	1.21	0.60
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	70.21	1.59	2.65
Smooth Muscle Cells - Prostate, donor1	11257-116F6	31.03	1.60	1.07
Smooth Muscle Cells - Prostate, donor2	11335-117F3	42.95	1.13	1.00
Smooth Muscle Cells - Prostate, donor3	11465-119B7	25.37	0.25	0.51
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	54.88	0.75	1.96
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	66.76	2.25	1.50
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	72.36	1.29	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	78.13	0.47	0.93
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	45.44	1.01	3.03
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	32.28	1.88	1.57
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	44.54	1.77	1.47
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	61.81	1.83	2.33
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	29.43	0.93	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	48.07	1.73	1.01
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	67.05	1.02	0.51
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	67.50	0.56	1.32
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	39.13	0.84	0.98
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	47.34	0.34	0.92
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	39.52	0.00	0.48
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	53.09	0.24	1.47
Smooth Muscle Cells - Uterine, donor1	11258-116F7	33.36	0.88	0.44
Smooth Muscle Cells - Uterine, donor3	11466-119B8	39.21	0.88	0.88
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	20.21	0.58	0.19
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	25.39	0.79	1.59
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	9.30	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	19.40	0.00	1.08
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	35.77	0.00	0.28
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	25.60	0.79	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	20.82	0.00	0.25
Smooth muscle cells - airway, control, donor2	11967-126D5	16.37	0.00	0.80
Smooth muscle cells - airway, control, donor3	11968-126D6	21.32	0.00	1.25
Smooth muscle cells - airway, control, donor4	11969-126D7	23.83	0.92	0.46
Synoviocyte, donor1	11291-117A4	32.32	0.67	0.67
Synoviocyte, donor2	11368-117I9	35.37	0.17	0.00
Synoviocyte, donor3	11440-118H9	25.92	0.00	0.22
Trabecular Meshwork Cells, donor1	11532-120A2	76.83	2.14	2.86
Trabecular Meshwork Cells, donor2	11612-122A1	49.55	0.00	1.98
Trabecular Meshwork Cells, donor3	11693-123A1	59.28	2.08	0.69
Tracheal Epithelial Cells, donor1	11292-117A5	33.98	0.72	0.57
Tracheal Epithelial Cells, donor2	11369-118A1	60.69	0.39	0.77
Tracheal Epithelial Cells, donor3	11441-118I1	45.81	0.00	2.86
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	77.01	0.74	1.35
Urethra, donor2	10319-105A4	61.15	0.00	0.00
Urothelial Cells, donor1	11520-119H8	32.68	0.27	0.27
Urothelial Cells, donor2	11600-120H7	32.05	0.40	0.00
Urothelial Cells, donor3	11681-122H7	32.78	0.23	1.15
Urothelial cells, donor0	11216-116B1	31.65	0.22	1.11
Whole blood (ribopure), donor090309, donation1	12179-129A1	19.58	0.00	2.67
Whole blood (ribopure), donor090309, donation2	12180-129A2	24.30	0.00	1.43
Whole blood (ribopure), donor090309, donation3	12181-129A3	10.95	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	22.38	0.69	0.69
Whole blood (ribopure), donor090325, donation2	12177-128I8	18.01	1.16	0.58
Whole blood (ribopure), donor090612, donation1	12182-129A4	14.58	0.00	1.04
Whole blood (ribopure), donor090612, donation2	12183-129A5	10.10	0.92	3.67
Whole blood (ribopure), donor090612, donation3	12184-129A6	29.21	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	72.29	1.36	1.60
Wilms' tumor cell line:HFWT	10597-108E3	98.56	1.76	0.88
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	33.80	0.56	0.56
achilles tendon, donor2	10292-104G4	33.06	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	65.27	1.27	0.51
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	72.21	0.93	1.86
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	49.38	2.85	0.95
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	75.92	0.27	1.36
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	52.28	1.97	1.97
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	57.73	0.85	1.06
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	17.42	0.82	0.82
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	49.79	0.00	1.32
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	37.98	1.63	0.41
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	65.62	0.39	0.39
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	45.63	2.58	3.86
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	46.81	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	57.17	1.63	0.70
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	52.30	1.55	1.55
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	56.11	0.58	1.17
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	48.80	0.00	0.46
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	36.19	0.41	1.65
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	36.83	1.53	1.23
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	40.11	0.85	0.85
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	39.73	1.52	2.43
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	43.33	1.20	1.44
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	43.43	1.34	1.34
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	41.69	2.33	1.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	59.46	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	23.73	0.38	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	49.72	0.00	1.74
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	89.97	1.87	0.00
adenocarcinoma cell line:IM95m	10796-110I4	103.62	0.71	1.18
adipose tissue, adult, pool1	10010-101C1	35.99	0.62	0.93
adipose, donor1	10184-103D4	60.99	1.17	1.17
adipose, donor2	10185-103D5	36.50	0.41	0.41
adipose, donor3	10186-103D6	38.12	0.82	1.36
adipose, donor4	10187-103D7	114.41	0.87	3.47
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	60.92	1.10	3.16
adrenal gland, adult, pool1	10081-102A9	94.58	3.64	3.64
adult T-cell leukemia cell line:ATN-1	10421-106C7	50.83	1.07	1.20
alveolar cell carcinoma cell line:SW 1573	10708-109H6	63.60	0.00	1.07
amniotic membrane cells, donor1	12235-129G3	35.24	0.23	0.70
amniotic membrane cells, donor2	12236-129G4	53.42	0.68	0.68
amniotic membrane cells, donor3	12237-129G5	25.04	0.29	0.00
amygdala - adult, donor10196	10167-103B5	28.46	7.11	0.00
amygdala, adult, donor10252	10151-102I7	43.19	1.82	2.03
amygdala, newborn, donor10223	10360-105E9	19.04	0.32	0.65
anaplastic carcinoma cell line:8305C	10428-106D5	37.56	0.64	1.40
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	56.26	2.65	2.43
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	63.80	0.67	0.00
aorta, adult, pool1	10052-101G7	32.95	0.59	0.00
appendix, adult	10189-103D9	46.57	1.16	0.78
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	49.18	1.38	1.03
artery, adult	10190-103E1	103.26	2.72	0.00
astrocytoma cell line:TM-31	10425-106D2	49.40	1.16	0.87
b cell line:RPMI1788	10427-106D4	36.73	1.78	0.74
basal cell carcinoma cell line:TE 354.T	10702-109G9	44.67	0.55	0.83
bile duct carcinoma cell line:HuCCT1	10432-106D9	49.42	1.49	2.38
bile duct carcinoma cell line:TFK-1	10496-107C1	42.51	2.51	3.18
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	40.82	0.56	2.24
bladder, adult, pool1	10011-101C2	30.64	0.87	0.54
blood, adult, pool1	10053-101G8	28.79	2.21	2.21
bone marrow stromal cell line:StromaNKtert	10686-109F2	42.82	0.00	0.86
bone marrow, adult	10192-103E3	26.32	0.00	0.00
brain, adult, donor1	10084-102B3	54.33	4.10	1.03
brain, adult, pool1	10012-101C3	46.66	3.23	1.56
brain, fetal, pool1	10085-102B4	58.77	8.01	0.00
breast carcinoma cell line:MCF7	10482-107A5	48.89	3.63	1.65
breast carcinoma cell line:MDA-MB-453	10419-106C5	45.81	1.87	1.50
breast, adult, donor1	10080-102A8	34.72	0.63	0.63
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	66.31	1.78	3.30
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	58.75	0.93	0.31
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	8.98	0.00	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	51.08	1.21	1.94
carcinoid cell line:NCI-H1770	10703-109H1	48.90	2.35	1.88
carcinoid cell line:NCI-H727	10735-110B6	59.72	1.97	1.64
carcinoid cell line:SK-PN-DW	10719-109I8	14.58	0.95	0.32
carcinosarcoma cell line:JHUCS-1	10642-109A3	50.04	2.40	1.33
caudate nucleus - adult, donor10196	10177-103C6	27.63	4.61	3.45
caudate nucleus, adult, donor10252	10164-103B2	39.82	2.68	2.68
caudate nucleus, adult, donor10258	10379-105H1	46.61	4.58	2.29
caudate nucleus, newborn, donor10223	10354-105E3	23.81	0.73	1.83
cerebellum - adult, donor10196	10173-103C2	52.44	0.00	2.91
cerebellum, adult, donor10252	10166-103B4	36.94	1.07	1.07
cerebellum, adult, pool1	10083-102B2	52.09	1.72	0.69
cerebellum, newborn, donor10223	10357-105E6	29.06	0.83	0.83
cerebral meninges, adult	10188-103D8	52.70	3.53	1.51
cerebrospinal fluid, donor2	10294-104G6	55.55	0.73	0.73
cervical cancer cell line:D98-AH2	10552-107I3	60.82	0.72	1.29
cervical cancer cell line:ME-180	10553-107I4	62.97	0.83	1.49
cervix, adult, pool1	10013-101C4	36.01	1.26	1.57
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	62.14	2.79	2.79
chondrosarcoma cell line:SW 1353	10700-109G7	56.17	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	32.56	1.37	0.62
choriocarcinoma cell line:SCH	10785-110H2	40.78	1.97	2.46
choriocarcinoma cell line:T3M-3	10618-108G6	40.08	1.66	3.79
chorionic membrane cells, donor1	12238-129G6	23.93	0.00	0.28
chorionic membrane cells, donor2	12239-129G7	42.95	0.99	0.89
chorionic membrane cells, donor3	12240-129G8	26.92	0.00	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	48.47	3.03	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	34.77	0.77	0.96
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	44.35	0.42	0.63
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	34.67	0.51	1.03
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	36.77	0.73	0.48
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	34.61	1.02	0.61
chronic myelogenous leukemia cell line:K562	10454-106G4	79.80	0.59	1.77
chronic myelogenous leukemia cell line:KU812	10409-106B4	61.25	1.04	0.78
clear cell carcinoma cell line:JHOC-5	10638-108I8	23.54	0.46	0.69
clear cell carcinoma cell line:TEN	10636-108I6	24.46	0.35	0.69
colon carcinoma cell line:CACO-2	10513-107D9	164.74	2.93	5.31
colon carcinoma cell line:COLO-320	10420-106C6	59.29	1.14	0.76
colon, adult, donor1	10082-102B1	66.64	1.19	0.00
colon, adult, pool1	10014-101C5	50.29	0.94	1.41
colon, fetal, donor1	10070-101I7	31.52	0.62	0.00
common myeloid progenitor CMP, donor1	12130-128D6	155.84	0.00	4.58
common myeloid progenitor CMP, donor2	12134-128E1	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	37.39	0.00	1.27
cord blood derived cell line:COBL-a 24h infection	10453-106G3	39.54	0.15	1.51
cord blood derived cell line:COBL-a untreated	10449-106F8	46.82	0.71	0.71
corpus callosum, adult, pool1	10042-101F6	47.21	2.43	1.66
cruciate ligament, donor2	10295-104G7	29.99	0.81	0.81
diaphragm, fetal, donor1	10069-101I6	64.21	0.00	0.00
diencephalon, adult	10193-103E4	34.56	1.20	1.68
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	54.19	1.15	0.46
ductal cell carcinoma cell line:KLM-1	10438-106E6	59.75	1.03	1.80
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	71.98	2.65	2.65
ductus deferens, adult	10196-103E7	49.34	0.50	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	40.33	1.44	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	46.35	0.74	0.00
dura mater, adult, donor1	10041-101F5	43.11	1.07	0.91
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	180.55	6.88	4.44
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	95.58	3.58	1.72
embryonic pancreas cell line:1B2C6	10604-108F1	35.15	0.00	1.85
embryonic pancreas cell line:1C3D3	10605-108F2	30.88	0.30	0.61
embryonic pancreas cell line:1C3IKEI	10606-108F3	42.92	1.23	1.85
embryonic pancreas cell line:2C6	10603-108E9	42.03	0.00	2.63
endometrial carcinoma cell line:OMC-2	10497-107C2	59.33	2.01	4.69
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	18.12	0.18	0.54
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	37.31	0.80	0.48
epidermoid carcinoma cell line:A431	10426-106D3	49.24	2.33	1.56
epidermoid carcinoma cell line:Ca Ski	10431-106D8	55.54	0.99	1.76
epididymis, adult	10197-103E8	37.68	1.05	1.67
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	40.27	0.89	0.71
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	31.07	1.57	1.97
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	72.47	1.05	1.57
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	70.37	1.87	1.77
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	89.51	1.68	1.46
esophagus, adult, pool1	10015-101C6	49.48	0.74	0.74
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	33.94	0.38	1.13
eye - muscle inferior rectus, donor1	10272-104E2	62.78	2.41	0.00
eye - muscle lateral, donor2	10298-104H1	88.38	2.10	2.10
eye - muscle medial, donor2	10299-104H2	108.64	1.49	0.00
eye - muscle superior, donor2	10297-104G9	58.47	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	46.64	0.00	0.00
eye, fetal, donor1	10054-101G9	32.80	1.02	0.00
fibrosarcoma cell line:HT-1080	10758-110E2	46.42	0.38	1.03
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	63.15	0.95	2.14
frontal lobe, adult, pool1	10040-101F4	48.23	4.03	2.16
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	70.86	1.20	1.50
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	38.77	0.82	1.10
gall bladder, adult	10198-103E9	46.84	0.72	2.66
gamma delta positive T cells, donor1	11937-126A2	31.67	1.61	0.00
gamma delta positive T cells, donor2	11938-126A3	28.39	0.00	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	93.99	3.80	3.59
gastric adenocarcinoma cell line:MKN45	10612-108F9	75.82	2.32	5.03
gastric cancer cell line:AZ521	10549-107H9	64.93	2.79	1.97
gastric cancer cell line:GSS	10560-108A2	51.25	0.00	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	33.58	0.46	0.91
giant cell carcinoma cell line:LU65	10487-107B1	42.34	1.72	2.07
giant cell carcinoma cell line:Lu99B	10433-106E1	34.43	0.98	0.84
glassy cell carcinoma cell line:HOKUG	10688-109F4	44.40	1.00	0.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	44.33	1.37	0.53
glioblastoma cell line:A172, tech_rep2	10444-106F3	63.20	0.98	0.70
glioblastoma cell line:T98G	10485-107A8	59.93	1.21	1.10
glioma cell line:GI-1	10413-106B8	30.17	1.17	0.88
globus pallidus - adult, donor10196	10175-103C4	39.36	0.00	2.19
globus pallidus, adult, donor10252	10161-103A8	37.59	1.46	1.46
globus pallidus, adult, donor10258	10367-105F7	39.71	1.37	0.00
globus pallidus, newborn, donor10223	10364-105F4	35.71	1.07	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	181.09	4.89	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	54.64	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	78.40	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	32.64	0.64	0.96
hIPS +CCl2, biol_rep1	14383-156B9	28.47	0.46	1.84
hIPS +CCl2, biol_rep2	14384-156C1	15.55	0.00	0.00
hIPS +CCl2, biol_rep3	14385-156C2	26.41	0.00	0.64
hIPS, biol_rep1	14380-156B6	23.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	28.81	0.69	0.69
hIPS, biol_rep3	14382-156B8	30.90	1.10	1.10
hairy cell leukemia cell line:Mo	10712-109I1	45.11	0.86	1.15
heart - mitral valve, adult	10205-103F7	36.18	0.60	0.60
heart - pulmonic valve, adult	10206-103F8	52.30	1.05	1.31
heart - tricuspid valve, adult	10207-103F9	49.13	2.50	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	82.64	0.82	1.43
heart, adult, diseased, donor1	10051-101G6	110.72	2.13	2.13
heart, adult, pool1	10016-101C7	126.95	2.07	2.07
heart, fetal, pool1	10046-101G1	69.00	0.72	1.64
hepatic mesenchymal tumor cell line:LI90	10778-110G4	39.80	0.31	1.23
hepatoblastoma cell line:HuH-6	10633-108I3	67.78	1.19	2.38
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	68.84	1.10	1.10
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	80.11	1.70	1.94
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	71.75	1.72	1.01
hepatoma cell line:Li-7	10484-107A7	69.40	1.00	2.56
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	69.55	4.62	3.52
hippocampus - adult, donor10196	10169-103B7	44.48	3.79	3.79
hippocampus, adult, donor10252	10153-102I9	44.70	2.86	1.63
hippocampus, adult, donor10258	10374-105G5	17.93	2.49	1.49
hippocampus, newborn, donor10223	10363-105F3	27.85	0.70	1.06
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	40.28	0.00	1.83
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	36.13	1.96	0.79
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	29.71	2.29	1.27
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	28.76	0.00	1.69
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	34.86	1.55	0.77
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	45.55	0.00	0.38
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	36.49	1.75	2.04
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	43.73	1.94	0.65
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	45.46	1.67	1.25
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	38.60	2.13	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	42.91	1.93	0.80
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	52.52	4.71	2.02
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	29.73	1.88	1.41
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	30.95	3.93	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	28.80	0.87	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	49.06	0.57	1.53
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	49.28	0.44	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	39.48	0.00	1.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	36.92	0.75	0.94
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	32.28	2.27	0.91
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	31.32	0.63	2.51
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	42.13	0.82	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	44.42	1.45	1.45
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	34.68	0.60	1.79
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	33.44	1.11	1.11
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	35.66	1.14	2.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	45.73	1.22	1.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	42.25	1.76	0.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	37.38	1.27	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	40.85	0.91	2.12
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	32.58	2.59	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	29.22	3.98	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	30.27	1.03	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	39.88	0.51	1.53
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	37.86	1.51	1.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	31.59	1.01	1.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	36.47	1.93	0.48
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	27.19	0.45	0.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	30.24	0.00	0.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	36.67	1.22	2.14
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	48.80	0.00	3.25
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	37.40	0.00	1.32
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	38.31	1.09	1.64
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	35.83	2.53	1.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	26.33	2.49	0.71
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	19.09	1.19	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	42.66	2.44	1.22
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	26.40	0.81	1.08
immature langerhans cells, donor1	11904-125F5	27.12	0.24	0.48
immature langerhans cells, donor2	11905-125F6	26.93	0.79	0.79
insula, adult, pool1	10039-101F3	55.55	4.16	3.03
keratoacanthoma cell line:HKA-1	10791-110H8	95.59	0.65	1.95
kidney, adult, pool1	10017-101C8	84.71	1.90	1.70
kidney, fetal, pool1	10045-101F9	59.35	2.41	1.91
large cell lung carcinoma cell line:IA-LM	10509-107D5	66.61	1.14	0.99
large cell lung carcinoma cell line:NCI-H460	10839-111E2	48.80	0.83	0.55
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	45.14	1.10	0.37
left atrium, adult, donor1	10079-102A7	55.57	1.09	0.00
left ventricle, adult, donor1	10078-102A6	79.89	1.52	0.00
leiomyoblastoma cell line:G-402	10721-110A1	68.13	1.37	2.19
leiomyoma cell line:10964C	10569-108B2	30.90	0.36	0.36
leiomyoma cell line:15242A	10570-108B3	28.80	2.17	0.54
leiomyoma cell line:15425	10571-108B4	34.97	1.21	1.46
leiomyosarcoma cell line:Hs 5.T	10722-110A2	25.40	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	46.00	1.05	2.09
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	60.92	0.47	0.83
liposarcoma cell line:KMLS-1	10782-110G8	44.21	0.78	1.56
liposarcoma cell line:SW 872	10726-110A6	58.48	0.73	0.97
liver, adult, pool1	10018-101C9	122.52	1.62	2.27
liver, fetal, pool1	10086-102B5	73.38	0.00	2.82
locus coeruleus - adult, donor10196	10182-103D2	46.96	2.19	1.60
locus coeruleus, adult, donor10252	10165-103B3	37.46	1.85	1.48
locus coeruleus, adult, donor10258	10375-105G6	36.11	1.13	1.13
locus coeruleus, newborn, donor10223	10362-105F2	15.14	1.26	0.42
lung adenocarcinoma cell line:A549	10499-107C4	46.36	2.77	2.35
lung adenocarcinoma cell line:PC-14	10408-106B3	61.36	0.00	0.69
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	116.66	1.19	0.53
lung, adult, pool1	10019-101D1	29.41	0.71	0.24
lung, fetal, donor1	10068-101I5	23.69	0.86	1.14
lung, right lower lobe, adult, donor1	10075-102A3	36.20	0.00	1.37
lymph node, adult, donor1	10077-102A5	37.40	0.47	1.42
lymphangiectasia cell line:DS-1	10727-110A7	48.00	1.32	1.75
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	54.18	2.11	1.81
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	40.78	2.55	0.85
mature adipocyte, donor1	12231-129F8	86.58	0.89	1.33
mature adipocyte, donor2	12232-129F9	64.54	0.42	1.66
mature adipocyte, donor3	12233-129G1	52.39	0.95	0.24
mature adipocyte, donor4	12234-129G2	56.85	0.79	0.79
maxillary sinus tumor cell line:HSQ-89	10414-106B9	36.22	2.38	0.95
medial frontal gyrus - adult, donor10196	10170-103B8	36.10	1.13	1.13
medial frontal gyrus, adult, donor10252	10150-102I6	46.34	3.31	0.55
medial frontal gyrus, adult, donor10258	10368-105F8	31.45	1.91	1.27
medial frontal gyrus, newborn, donor10223	10352-105E1	23.88	2.13	0.43
medial temporal gyrus - adult, donor10196	10183-103D3	42.36	2.03	1.52
medial temporal gyrus, adult, donor10252	10156-103A3	44.14	2.33	1.27
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	21.19	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	71.77	0.00	14.35
medial temporal gyrus, newborn, donor10223	10353-105E2	24.41	2.15	0.36
medulla oblongata - adult, donor10196	10174-103C3	30.50	0.65	1.95
medulla oblongata, adult, donor10252	10155-103A2	31.58	1.55	0.93
medulla oblongata, adult, pool1	10038-101F2	37.88	2.04	1.80
medulla oblongata, newborn, donor10223	10361-105F1	26.04	1.04	2.78
medulloblastoma cell line:D283 Med	10838-111E1	81.48	1.55	0.89
medulloblastoma cell line:ONS-76	10759-110E3	58.08	0.73	0.86
melanoma cell line:COLO 679	10514-107E1	41.11	1.01	0.57
melanoma cell line:G-361	10465-106H6	33.39	0.54	1.90
meningioma cell line:HKBMM	10691-109F7	35.28	0.36	1.27
merkel cell carcinoma cell line:MKL-1	10843-111E6	64.32	0.88	2.64
merkel cell carcinoma cell line:MS-1	10844-111E7	82.43	2.07	2.85
mesenchymal precursor cell - adipose, donor1	11747-123G1	54.01	0.31	1.53
mesenchymal precursor cell - adipose, donor2	11748-123G2	41.08	0.73	1.27
mesenchymal precursor cell - adipose, donor3	11749-123G3	28.16	0.41	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	30.34	0.56	0.42
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	36.40	0.00	0.39
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	27.07	0.69	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	30.04	0.69	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	31.17	1.15	0.58
mesenchymal precursor cell - cardiac, donor3	11754-123G8	37.01	0.40	0.93
mesenchymal precursor cell - cardiac, donor4	11755-123G9	27.55	1.22	1.08
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	22.34	1.28	0.57
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	23.38	0.00	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	31.27	0.69	0.69
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	25.48	0.35	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	28.58	0.41	0.61
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	17.25	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	26.48	0.31	1.55
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	22.34	0.23	0.46
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	34.82	0.42	0.42
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	30.34	0.90	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	26.35	0.61	0.88
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	23.56	0.74	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	24.61	1.14	0.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	53.47	2.11	1.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	42.47	0.46	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	35.55	0.26	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	40.83	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	38.51	0.92	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	36.01	0.00	0.47
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	36.89	1.02	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	37.33	0.39	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	31.51	0.46	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	41.53	0.58	0.58
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	35.03	0.67	0.45
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	37.01	0.96	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	40.33	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	34.24	0.34	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	33.98	0.82	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	39.95	0.86	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	38.28	0.00	2.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	30.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	40.92	0.32	0.97
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	52.38	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	45.84	1.07	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	29.44	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	38.09	0.78	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	52.47	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	26.82	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	42.90	0.00	4.77
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	36.76	0.00	1.19
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	36.55	0.00	3.66
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	48.77	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	28.63	0.34	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	34.39	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	7.98	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	20.66	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	31.38	0.00	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	27.81	0.00	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	28.89	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	30.24	0.31	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	22.72	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	46.12	1.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	41.09	2.57	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	57.14	1.38	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	73.23	0.99	1.48
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	49.35	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	62.33	1.91	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	91.07	1.61	1.61
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	109.03	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	87.43	1.27	3.80
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	59.47	0.61	1.21
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	54.23	0.00	4.52
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	56.83	0.82	1.65
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	39.09	0.40	0.40
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	44.78	0.00	1.30
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	51.95	0.00	2.04
mesodermal tumor cell line:HIRS-BM	10696-109G3	44.88	0.77	1.55
mesothelioma cell line:ACC-MESO-1	10493-107B7	67.09	1.42	2.60
mesothelioma cell line:ACC-MESO-4	10494-107B8	73.44	0.23	1.62
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	59.83	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	77.58	0.51	0.92
mesothelioma cell line:Mero-25	10850-111F4	65.14	1.13	1.82
mesothelioma cell line:Mero-41	10851-111F5	44.74	0.98	1.71
mesothelioma cell line:Mero-48a	10852-111F6	48.49	1.55	1.77
mesothelioma cell line:Mero-82	10853-111F7	53.88	0.53	1.58
mesothelioma cell line:Mero-83	10854-111F8	48.34	1.87	1.02
mesothelioma cell line:Mero-84	10855-111F9	52.83	0.76	1.26
mesothelioma cell line:Mero-95	10856-111G1	48.45	0.62	1.66
mesothelioma cell line:NCI-H2052	10847-111F1	45.22	0.99	1.49
mesothelioma cell line:NCI-H226	10846-111E9	57.92	0.36	0.36
mesothelioma cell line:NCI-H2452	10848-111F2	46.12	0.68	1.54
mesothelioma cell line:NCI-H28	10845-111E8	36.13	3.05	1.27
mesothelioma cell line:No36	10857-111G2	65.89	0.65	3.26
mesothelioma cell line:ONE58	10858-111G3	39.02	1.90	0.54
migratory langerhans cells, donor1	11901-125F2	22.07	0.38	0.38
migratory langerhans cells, donor2	11902-125F3	22.23	0.24	0.49
migratory langerhans cells, donor3	11903-125F4	32.13	0.72	0.54
mixed mullerian tumor cell line:HTMMT	10689-109F5	33.63	3.26	0.98
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	59.55	2.12	3.18
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	84.54	0.69	1.61
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	44.34	0.95	0.57
myelodysplastic syndrome cell line:SKM-1	10772-110F7	63.94	5.17	4.25
myeloma cell line:PCM6	10474-106I6	62.86	1.58	1.58
myxofibrosarcoma cell line:MFH-ino	10600-108E6	68.48	0.00	1.52
myxofibrosarcoma cell line:NMFH-1	10684-109E9	37.27	0.59	0.39
nasal epithelial cells, donor1, tech_rep1	12226-129F3	36.21	1.45	2.34
nasal epithelial cells, donor1, tech_rep2	12226-129F3	30.15	1.69	1.62
nasal epithelial cells, donor2	12227-129F4	66.24	0.00	2.21
neuroblastoma cell line:CHP-134	10508-107D4	97.09	1.84	0.23
neuroblastoma cell line:NB-1	10539-107G8	68.66	1.12	0.56
neuroblastoma cell line:NBsusSR	10607-108F4	61.16	1.90	2.11
neuroblastoma cell line:NH-12	10555-107I6	21.80	0.56	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	25.38	0.95	0.95
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	43.55	1.74	1.90
neuroectodermal tumor cell line:TASK1	10774-110F9	58.57	2.62	2.82
neuroepithelioma cell line:SK-N-MC	10728-110A8	61.03	3.81	4.45
neurofibroma cell line:Hs 53.T	10729-110A9	44.72	0.53	0.00
neutrophil PMN, donor1	12133-128D9	133.87	0.00	0.00
neutrophil PMN, donor2	12137-128E4	66.40	0.00	0.00
neutrophil PMN, donor3	12141-128E8	37.88	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	36.36	0.51	0.51
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	97.66	2.40	2.40
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	38.47	1.92	0.64
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	33.11	0.79	1.05
nucleus accumbens, adult, pool1	10037-101F1	43.12	3.37	1.59
occipital cortex - adult, donor10196	10172-103C1	55.63	4.12	2.06
occipital cortex, adult, donor10252	10163-103B1	47.77	2.15	1.07
occipital cortex, newborn, donor10223	10355-105E4	29.12	1.82	1.46
occipital lobe, adult, donor1	10076-102A4	53.27	2.62	2.10
occipital lobe, fetal, donor1	10073-102A1	55.78	5.15	3.00
occipital pole, adult, pool1	10036-101E9	50.14	4.26	2.29
olfactory region, adult	10195-103E6	37.26	1.91	0.38
optic nerve, donor1	10277-104E7	42.02	0.00	2.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	33.38	1.71	1.59
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	57.02	1.24	2.61
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	31.49	0.68	0.51
oral squamous cell carcinoma cell line:SAS	10544-107H4	60.30	1.50	2.08
osteoclastoma cell line:Hs 706.T	10704-109H2	33.22	1.18	1.47
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	31.77	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	39.87	0.85	0.42
ovary, adult, pool1	10020-101D2	32.32	0.87	1.75
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	60.31	1.47	1.28
pancreas, adult, donor1	10049-101G4	74.31	0.94	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	31.03	1.12	1.12
papillary adenocarcinoma cell line:8505C	10437-106E5	38.50	1.53	1.02
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	62.92	0.83	1.32
paracentral gyrus, adult, pool1	10035-101E8	49.97	3.29	1.74
parietal cortex, adult, donor10258	10373-105G4	28.63	1.47	0.00
parietal lobe - adult, donor10196	10171-103B9	50.79	3.76	0.00
parietal lobe, adult, donor10252	10157-103A4	37.91	2.00	2.00
parietal lobe, adult, pool1	10034-101E7	53.49	3.26	2.29
parietal lobe, fetal, donor1	10072-101I9	57.22	10.67	1.94
parietal lobe, newborn, donor10223	10356-105E5	25.80	3.74	1.87
parotid gland, adult	10199-103F1	50.57	1.23	0.62
penis, adult	10200-103F2	35.99	0.54	1.07
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	25.85	0.93	1.12
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	52.01	2.04	1.46
pineal gland - adult, donor10196	10179-103C8	28.38	1.94	1.29
pineal gland, adult, donor10252	10160-103A7	39.68	0.59	0.59
pineal gland, adult, donor10258	10377-105G8	33.86	0.63	0.00
pituitary gland - adult, donor10196	10180-103C9	30.35	1.01	0.00
pituitary gland, adult, donor10252	10162-103A9	51.60	1.04	0.52
pituitary gland, adult, donor10258	10378-105G9	28.09	2.55	0.00
placenta, adult, pool1	10021-101D3	32.04	0.65	0.32
plasma cell leukemia cell line:ARH-77	10840-111E3	40.92	0.93	1.19
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	18.21	0.62	0.16
pons, adult, pool1	10033-101E6	37.35	3.70	1.98
postcentral gyrus, adult, pool1	10032-101E5	55.44	3.49	1.74
promyelocytes/myelocytes PMC, donor1	12132-128D8	154.76	4.18	4.18
promyelocytes/myelocytes PMC, donor2	12136-128E3	33.05	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	93.89	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	64.67	1.60	1.46
prostate cancer cell line:PC-3	10439-106E7	56.99	0.91	1.63
prostate, adult, pool1	10022-101D4	31.38	0.91	0.82
putamen, adult, donor10196	10176-103C5	46.98	3.78	3.07
putamen, adult, donor10252	10152-102I8	58.82	1.96	7.84
putamen, adult, donor10258, tech_rep1	10372-105G3	21.86	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	28.51	1.69	0.97
putamen, newborn, donor10223	10365-105F5	11.99	0.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	47.13	0.87	1.16
rectum, fetal, donor1	10067-101I4	62.59	4.17	2.78
renal cell carcinoma cell line:OS-RC-2	10411-106B6	39.22	1.27	0.85
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	27.75	0.00	0.00
retina, adult, pool1	10030-101E3	42.24	1.79	1.19
retinoblastoma cell line:Y79	10475-106I7	51.18	1.30	0.26
rhabdomyosarcoma cell line:KYM-1	10787-110H4	44.51	2.34	1.97
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	59.33	3.09	2.81
sacrococcigeal teratoma cell line:HTST	10695-109G2	49.26	3.03	0.76
salivary acinar cells, donor1	11771-123I7	28.97	0.16	0.65
salivary acinar cells, donor2	11772-123I8	23.27	0.41	0.69
salivary acinar cells, donor3	11773-123I9	40.39	0.00	0.00
salivary gland, adult, pool1	10093-102C3	42.32	2.29	1.14
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	27.65	1.43	1.26
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	36.79	2.47	1.18
seminal vesicle, adult	10201-103F3	42.33	1.06	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	24.78	0.24	0.24
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	16.86	1.01	0.75
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	21.07	1.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	34.25	0.40	0.54
signet ring carcinoma cell line:Kato III	10436-106E4	54.16	2.32	3.43
signet ring carcinoma cell line:NUGC-4	10483-107A6	41.29	0.26	0.13
skeletal muscle - soleus muscle, donor1	10282-104F3	163.15	8.51	7.80
skeletal muscle, adult, pool1	10023-101D5	146.44	5.04	5.88
skeletal muscle, fetal, donor1	10066-101I3	43.22	2.01	2.01
skin, adult, donor1	10074-102A2	13.57	0.00	0.00
skin, fetal, donor1	10065-101I2	48.60	1.89	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	77.38	4.34	1.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	50.43	0.63	0.63
small cell lung carcinoma cell line:DMS 144	10841-111E4	61.10	1.73	1.73
small cell lung carcinoma cell line:LK-2	10541-107H1	55.55	1.81	1.32
small cell lung carcinoma cell line:NCI-H82	10842-111E5	43.59	0.64	0.32
small cell lung carcinoma cell line:WA-hT	10562-108A4	65.81	0.87	0.65
small intestine, adult, pool1	10024-101D6	59.24	2.03	1.19
small intestine, fetal, donor1	10064-101I1	38.08	0.74	0.74
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	19.49	2.05	0.51
smooth muscle, adult, pool1	10048-101G3	33.34	0.78	0.78
somatostatinoma cell line:QGP-1	10781-110G7	38.60	0.27	0.54
spinal cord - adult, donor10196	10181-103D1	45.88	2.06	0.46
spinal cord, adult, donor10252	10159-103A6	29.57	0.39	0.79
spinal cord, adult, donor10258	10369-105F9	16.60	1.38	1.38
spinal cord, fetal, donor1	10056-101H2	70.13	1.22	2.44
spinal cord, newborn, donor10223	10359-105E8	33.98	1.38	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	47.49	0.60	0.75
spleen, adult, pool1	10025-101D7	38.55	1.21	0.66
spleen, fetal, pool1	10044-101F8	34.48	1.03	0.72
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	40.37	1.66	1.66
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	48.99	0.00	1.90
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	47.87	0.35	0.35
squamous cell carcinoma cell line:T3M-5	10616-108G4	46.13	1.17	2.74
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	54.93	3.94	3.15
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	69.89	1.69	2.97
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	16.08	0.00	0.00
stomach, fetal, donor1	10062-101H8	81.17	0.00	0.00
submaxillary gland, adult	10202-103F4	48.99	0.57	0.57
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	31.78	0.83	0.62
substantia nigra, adult, donor10258	10371-105G2	26.38	1.55	0.52
substantia nigra, newborn, donor10223	10358-105E7	23.32	0.71	1.41
synovial sarcoma cell line:HS-SY-II	10441-106E9	52.50	1.15	1.60
temporal lobe, adult, pool1	10031-101E4	59.76	4.15	4.15
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	50.57	4.27	2.85
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	31.65	4.40	1.32
tenocyte, donor1	11763-123H8	48.53	0.00	1.05
tenocyte, donor2	11765-123I1	37.77	0.38	1.14
tenocyte, donor3	11768-123I4	28.91	0.37	1.11
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	75.63	1.87	3.06
teratocarcinoma cell line:NCR-G1	10798-110I6	42.08	1.39	1.39
teratocarcinoma cell line:PA-1	10807-111A6	39.36	0.77	1.70
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	70.33	2.03	1.78
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	37.06	1.89	1.13
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	32.39	1.20	1.31
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	55.70	3.58	2.28
testis, adult, pool1	10026-101D8	74.09	5.37	3.22
testis, adult, pool2	10096-102C6	67.66	4.06	2.71
thalamus - adult, donor10196	10168-103B6	38.64	3.31	1.10
thalamus, adult, donor10252	10154-103A1	30.48	1.09	0.78
thalamus, adult, donor10258, tech_rep1	10370-105G1	26.17	3.08	3.08
thalamus, adult, donor10258, tech_rep2	10370-105G1	35.08	1.48	0.66
thalamus, newborn, donor10223	10366-105F6	21.29	1.15	1.73
throat, adult	10209-103G2	52.93	0.50	0.75
throat, fetal, donor1	10061-101H7	55.46	0.91	2.13
thymic carcinoma cell line:Ty-82	10803-111A2	62.60	1.19	1.79
thymus, adult, pool1	10027-101D9	54.48	3.78	1.79
thymus, fetal, pool1	10043-101F7	33.77	1.87	1.25
thyroid carcinoma cell line:KHM-5M	10776-110G2	44.41	0.53	0.53
thyroid carcinoma cell line:TCO-1	10783-110G9	48.05	1.82	1.26
thyroid, adult, pool1	10028-101E1	53.93	0.84	0.75
thyroid, fetal, donor1	10060-101H6	53.52	1.05	2.11
tongue epidermis (fungiform papillae), donor1	10288-104F9	92.39	0.00	0.00
tongue, adult	10203-103F5	61.17	1.16	0.70
tongue, fetal, donor1	10059-101H5	72.12	0.79	0.79
tonsil, adult, pool1	10047-101G2	49.29	1.00	0.30
trachea, adult, pool1	10029-101E2	39.26	0.57	0.41
trachea, fetal, donor1	10058-101H4	57.70	1.15	1.15
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	43.58	0.71	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	43.06	2.33	2.33
transitional-cell carcinoma cell line:JMSU1	10492-107B6	40.27	1.25	1.25
tridermal teratoma cell line:HGRT	10694-109G1	57.08	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	50.96	0.85	1.02
umbilical cord, fetal, donor1	10057-101H3	39.64	0.00	2.09
uterus, adult, pool1	10100-102D1	23.89	0.68	0.51
uterus, fetal, donor1	10055-101H1	52.22	2.56	0.00
vagina, adult	10204-103F6	23.26	0.65	0.00
vein, adult	10191-103E2	36.17	0.22	0.66
xeroderma pigentosum b cell line:XPL 17	10563-108A5	35.52	2.40	0.27